Director/PDMR Shareholding

Summary by AI BETAClose X

On October 8, 2025, Judges Scientific plc announced that the Trustees of the Share Incentive Plan purchased ordinary shares on behalf of several Directors/PDMRs on October 6, 2025. For Chief Executive Officer David Cicurel, 3 shares were purchased. For Chief Financial Officer Bradley Ormsby, 4 shares were purchased. For Chief Operating Officer Mark Lavelle, 3 shares were purchased. For Group Business Development Director Tim Prestidge, 4 shares were purchased. For Group Commercial Director Ian Wilcock, 3 shares were purchased. The price for each of these transactions was 6285.0p per share, and the transactions occurred on the London Stock Exchange, AIM Market (XLON).

Disclaimer*

UK 100

Latest directors dealings